• Explore /
  • Poster
  • / Phase II trial of umbilical cord blood-derived natural killer cells for multiple myeloma.

Phase II trial of umbilical cord blood-derived natural killer cells for multiple myeloma.

Abstract Poster

Authors

Nina Shah

Nina Shah

The University of Texas MD Anderson Cancer Center, Houston, TX

Nina Shah , Li Li , Jessica Mccarty , Indreshpal Kaur , Eric Yvon , Robert Z. Orlowski , Laurence Cooper , Simrit Parmar , Kai Cao , Chitra Hosing , Sairah Ahmed , Yago Nieto , Krina K. Patel , Qaiser Bashir , Stephanie Kent , Catherine Bollard , Richard E. Champlin , Katayoun Rezvani , Elizabeth J. Shpall

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Cellular Immunotherapy

Clinical Trial Registration Number

NCT01729091

Citation

J Clin Oncol 34, 2016 (suppl; abstr TPS3100)

DOI

10.1200/JCO.2016.34.15_suppl.TPS3100

Abstract #

TPS3100

Poster Bd #

419b

Abstract Disclosures

Similar Posters

First Author: Dagmar Hess

First Author: Juan Martin-Liberal

First Author: Jesse Meir Zaretsky

First Author: Brittany K. Ragon